CD40 and atherosclerosis: Lutgens [137] also reported that deficiency in hematopoietic CD40 in Ldlr−/− mice or genetic interruption of CD40-TRAF6 signaling in ApoE−/− mice reduces atherosclerosis and increases plaque fibrosis.